You, Abin <br/><br/>
Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.  [electronic resource] 

 -  Journal of hematology & oncology  Mar 2016 
 - 20 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-8722 
<br/><br/><label>Standard No.: </label>10.1186/s13045-016-0253-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetyltransferases--metabolism<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Basic Helix-Loop-Helix Transcription Factors--metabolism<br/>Blotting, Western<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Hypoxia<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Metformin--administration & dosage<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Sorafenib<br/>Transcription Factors--metabolism<br/>Xenograft Model Antitumor Assays